Clinical Trial Update: Efficacy and Safety of CKD-828 to Stage 2 Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial assessing CKD-828 for stage 2 hypertension has completed. The update reports on the efficacy and safety findings from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-828

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 3 | Status: COMPLETED